Jam
-
IREN Names Anthony Lewis Chief Capital Officer, Taps Him for Capital Markets Strategy
IREN Limited has appointed Anthony Lewis as its new Chief Capital Officer to bolster its capital markets strategy and fuel aggressive growth in the AI infrastructure sector. Lewis brings over two decades of financial markets experience, including a significant tenure at Macquarie Group, to shape IREN’s capital structure and financing initiatives.
-
Camurus’ Oczyesa® Approved for Acromegaly Treatment in EU
The European Commission has granted marketing authorization for Oczyesa®, the first once-monthly subcutaneous octreotide for acromegaly maintenance treatment. This formulation offers convenient self-administration via a pre-filled autoinjector pen. Clinical trials showed Oczyesa® achieves effective disease control, improves symptoms, and enhances quality of life for acromegaly patients.
-
Argo Places First Graphene Purchase Order
Argo Living Soils Corp. is entering the advanced construction materials sector with its first supply order of liquid graphene oxide. This high-grade product, derived from pure vein graphite, will be integrated into concrete formulations to enhance performance and sustainability. The company also announced marketing and investor relations initiatives to boost its profile.
-
Endeavour to Release Q2 and First Half 2025 Results on July 31, 2025
Endeavour Mining will announce its Q2 and half-year 2025 financial results on July 31, 2025, before the London Stock Exchange opens. A conference call and webcast will follow at 8:30 AM EDT / 1:30 PM BST, with playback available on the company’s website. Investor relations contact is Jack Garman.
-
KKR Launches Singapore-Based Ascend Asia Financial Advisory Platform
KKR has launched Ascend Asia, a new financial advisory platform in Singapore, led by former Prudential Singapore CEO Tomas Urbanec. Ascend Asia acquired finexis advisory, making it the platform’s first member. The initiative aims to elevate financial advisory services in Singapore through enhanced client service, best practices, and strategic resources for member firms.
-
Golden Goliath Resources Announces Board Resignation
Golden Goliath Resources Ltd. announced the immediate resignation of Mr. Daniel Nofrietta Fernandez from its Board of Directors. The company expressed gratitude for his contributions and is actively seeking replacements as part of a strategic review to enhance shareholder value and guide future growth.
-
TELUS Prices Tender Offers for Eight Debt Series
TELUS Corporation has finalized pricing for its cash tender offers to repurchase outstanding notes. This strategic debt management move specifies terms for various series of senior notes maturing between 2030 and 2051. The company expects to settle these transactions on July 3, 2025. RBC Dominion Securities Inc. and others are managing the offers.
-
Tutor Perini Wins $1.87 Billion Midtown Bus Terminal Staging and Storage Project
Tutor Perini Corporation has been awarded a $1.87 billion contract by the Port Authority of New York and New Jersey for the Midtown Bus Terminal Redevelopment Program. The project includes constructing a seven-story bus storage facility and a ramp structure to facilitate bus movement. Construction is set to begin in fall 2025, with completion of funded portions expected by fall 2028.
-
Toll Brothers Announces Final Homes Available at Murphy’s Crescent Hill
Toll Brothers announces a final opportunity to purchase a luxury home at Crescent Hill in Murphy, Texas. This community offers spacious one- and two-story designs with 4-6 bedrooms and upscale finishes, priced from the mid-$700,000s. Residents benefit from the Plano school district and convenient access to amenities. Quick move-in homes are available.
-
ANGLE PLC: 2025 AGM Results Announced
ANGLE plc announced all resolutions were passed at its 2025 Annual General Meeting. The global leader in liquid biopsy technology, known for its Parsortix® PC1 System, focuses on circulating tumor cell (CTC) solutions for research, drug development, and clinical oncology. The company offers clinical services and diagnostic products, backed by over 100 peer-reviewed publications.